triptolide has been researched along with Adenoma, Basal Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Lei, T; Li, R; Shu, K; Sun, W; Wang, J; Zhang, H; Zhang, Z | 1 |
1 other study(ies) available for triptolide and Adenoma, Basal Cell
| Article | Year |
|---|---|
Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.
Topics: ADAM12 Protein; Adenoma; Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Movement; Cell Survival; Diterpenes; Epoxy Compounds; ErbB Receptors; Mice; Phenanthrenes; Pituitary Gland; Pituitary Neoplasms; Signal Transduction | 2018 |